Arbovax Company
![](/storage/logos_100px/Arbovax.jpg)
Arbovax engages in the preclinical and clinical development of vaccine products for the prophylactic treatment of arthropod-borne diseases.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Raleigh, North Carolina, United States
Founded Date:
2005
Employees Number:
1-10
Estimated Revenue:
$1M to $10M
Register and Claim Ownership